MedTrace Logo

Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome

NCT06124300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-08-23

No results posted yet for this study

Summary

This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnaires will be completed at baseline, 1 week, 2 weeks, 4 weeks, and 12 weeks

Conditions

  • Polycystic Ovary Syndrome
  • Premenstrual Syndrome

Interventions

DIETARY_SUPPLEMENT

Female Hormone Balance Supplement

The product contains: Myo-Inositol D-Chiro Inositol Folic Acid Vitamin D Vitamin B12

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • Rael

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-30
Primary Completion
2024-01-19
Completion
2024-01-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124300 on ClinicalTrials.gov